A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Status:
Completed
Trial end date:
2010-03-02
Target enrollment:
Participant gender:
Summary
To compare how well the new formulation of Tacrolimus® used once daily, in combination with
other drugs helps prevent the rejection of a new kidney after transplantation compared to the
twice daily dose of Tacrolimus